Table III.
Characteristics of patients with bleeding from peptic ulcers.
| Patient no. | Diagnosis | Gender | Age | Disease | NSAIDs | Immunosuppressive agents | Corticosteroids | History of peptic ulcers | H. pylori |
|---|---|---|---|---|---|---|---|---|---|
| 1 | GU | F | 79 | Lumbar discopathy | (+) | (−) | (−) | (−) | NA |
| 2 | GU | M | 73 | RA | (−) | (−) | (+) | (−) | NA |
| 3 | GU | M | 73 | RA | (−) | (−) | (+) | (−) | NA |
| 4 | GU | M | 73 | RA | (−) | (−) | (+) | (−) | NA |
| 5 | GU | F | 66 | (−) | (−) | (+) | (−) | (−) | NA |
| 6 | GU | F | 67 | RA | (−) | (+) | (−) | (−) | NA |
| 7 | GU | M | 22 | DMD | (−) | (−) | (−) | (−) | NA |
| 8 | GU | M | 78 | (−) | (−) | (−) | (−) | (−) | NA |
| 9 | GU | M | 72 | (−) | (−) | (−) | (−) | (+) | NA |
| 10 | GU | M | 72 | (−) | (−) | (−) | (−) | (+) | NA |
| 11 | GU | M | 84 | (−) | (−) | (−) | (−) | (−) | NA |
| 12 | GU | M | 71 | (−) | (−) | (−) | (−) | (−) | NA |
| 13 | GU | F | 70 | (−) | (−) | (−) | (−) | (−) | NA |
| 14 | GU | M | 69 | (−) | (−) | (−) | (−) | (+) | (+) |
| 15 | GU | F | 84 | (−) | (−) | (−) | (−) | (−) | NA |
| 16 | GU | F | 87 | (−) | (−) | (−) | (−) | (−) | NA |
| 17 | GU | F | 70 | (−) | (−) | (−) | (−) | (−) | (+) |
| 18 | DG | F | 42 | (−) | (−) | (−) | (−) | (−) | (−) |
| 19 | DG | F | 42 | (−) | (−) | (−) | (−) | (−) | (−) |
NSAIDs, non-steroidal anti-inflammatory drugs; GU, gastric ulcer; DG, duodenal ulcer; M, male; F, female; RA, rheumatoid arthritis; DMD, Duchenne muscular dystrophy; NA, not analyzed; H. pylori, Helicobacter pylori.